Healio Gastroenterology and Liver Disease 200

Leading Innovators in the Field of Gastroenterology and Hepatology

In 2016, SLACK Incorporated, publisher of Healio Gastroenterology and Liver Disease, welcomed members of the newly minted Healio Gastroenterology and Liver Disease 200. The editors and publisher of Healio Gastroenterology and Liver Disease compiled the inaugural list of gastroenterology and hepatology professionals identified as leading innovators across various specialties from inflammatory bowel disease to endoscopy, and from hepatitis C virus to esophageal disease.

We gathered together the names of clinicians, educators and researchers working to reshape the fields of gastroenterology and hepatology. The list became a compilation of physicians who work to educate their colleagues, conduct research into new and novel technologies to advance the profession, and innovate the unique aspects of gastroenterology and hepatology.

Three years later, the editors and publisher of Healio Gastroenterology and Liver Disease have reviewed the list and added new professionals who have burst onto the scene over the last several years. We utilized our knowledge and experience with these individuals and incorporated the input of our Peer Perspective Board members.

Click here to see the list.

Admittedly, we may have missed other innovators, but we believe the list represents the ever-changing fields. Gastroenterology and hepatology are constantly changing and growing fields of medical practice, and our hope is the Healio Gastroenterology and Liver Disease 200 will continue to be a tool for kick-starting conversations and expanding your voice in health care. We will continue to use the Healio Gastroenterology and Liver Disease 200 to encourage discussion and to share viewpoints about issues facing physicians in gastroenterology and hepatology. We will continue to survey members of our Healio Gastroenterology and Liver Disease 200 to gather insight on the latest debates in the field and reaching out for their perspectives on FDA approvals, guidelines and the newest data both published and presented.

Do you want to join the discussion? If so, please reach out to us, share your ideas and feel free to note if you believe yourself or a colleague needs to be on the list. We look forward to your ideas on how we can do even better for our readers and the gastroenterology community as a whole.

Katrina Altersitz
Editorial Director
Healio Gastroenterology and Liver Disease
kaltersitz@healio.com

In 2016, SLACK Incorporated, publisher of Healio Gastroenterology and Liver Disease, welcomed members of the newly minted Healio Gastroenterology and Liver Disease 200. The editors and publisher of Healio Gastroenterology and Liver Disease compiled the inaugural list of gastroenterology and hepatology professionals identified as leading innovators across various specialties from inflammatory bowel disease to endoscopy, and from hepatitis C virus to esophageal disease.

We gathered together the names of clinicians, educators and researchers working to reshape the fields of gastroenterology and hepatology. The list became a compilation of physicians who work to educate their colleagues, conduct research into new and novel technologies to advance the profession, and innovate the unique aspects of gastroenterology and hepatology.

Three years later, the editors and publisher of Healio Gastroenterology and Liver Disease have reviewed the list and added new professionals who have burst onto the scene over the last several years. We utilized our knowledge and experience with these individuals and incorporated the input of our Peer Perspective Board members.

Click here to see the list.

Admittedly, we may have missed other innovators, but we believe the list represents the ever-changing fields. Gastroenterology and hepatology are constantly changing and growing fields of medical practice, and our hope is the Healio Gastroenterology and Liver Disease 200 will continue to be a tool for kick-starting conversations and expanding your voice in health care. We will continue to use the Healio Gastroenterology and Liver Disease 200 to encourage discussion and to share viewpoints about issues facing physicians in gastroenterology and hepatology. We will continue to survey members of our Healio Gastroenterology and Liver Disease 200 to gather insight on the latest debates in the field and reaching out for their perspectives on FDA approvals, guidelines and the newest data both published and presented.

Do you want to join the discussion? If so, please reach out to us, share your ideas and feel free to note if you believe yourself or a colleague needs to be on the list. We look forward to your ideas on how we can do even better for our readers and the gastroenterology community as a whole.

Katrina Altersitz
Editorial Director
Healio Gastroenterology and Liver Disease
kaltersitz@healio.com